TABLE 1.
Demographic and clinical data for the study participants included in the study analysis
| Parameter | Value [no. (%) or as indicated] for: |
|
|---|---|---|
| TB patients | Controls | |
| No. of participants | 89 | 99 |
| Age (mean yrs ± SD) | 40.6 ± 14.4 | 41.8 ± 10.7 |
| Male | 65 (72) | 30 (30) |
| Ethnicity | ||
| European | 46 (52) | 95 (96) |
| African | 16 (18) | 0 (0) |
| Asian | 15 (17) | 4 (4) |
| South America | 9 (10) | 0 (0) |
| Not announced | 3 (3) | 0 (0) |
| PCR/culture result | ||
| Positivea | 83 (93) | 0 (0) |
| Negative | 5 (6) | 0 (0) |
| Not done | 1 (1) | 99 (100) |
| In treatment | ||
| Yes | 77 (87) | 0 (0) |
| No | 12 (13) | 99 (100) |
| Not announced | 0 (0) | |
| Mean time of treatment (days) | 22.6 | |
| Previous TB infection | ||
| Yes | 12 (13) | 0 (0) |
| No | 64 (72) | 99 (100) |
| Unknown | 13 (15) | 0 (0) |
| Previous TB treatment | ||
| Yes | 8 (9) | 0 (0) |
| No | 54 (61) | 95 (96) |
| Unknown | 27 (30) | 4 (4) |
| BCG vaccinated | ||
| Yes | 35 (39) | 45 (45) |
| No | 27 (30) | 42 (42) |
| Unknown | 27 (30) | 12 (12) |
| HIV infected | ||
| Yes | 3 (3) | 0 (0) |
| No | 66 (74) | 96 (97) |
| Unknown | 20 (23) | 3 (3) |
| Other immunosuppression | ||
| Yes | 3 (3) | |
| No | 86 (97) | |
| Unknown | 0 (0) | |
| QFT result | ||
| Positive | 80 (90) | 0 (0) |
| Negative | 9 (10) | 99 (100) |
| Indeterminate | 0 (0) | 0 (0) |
| Close contact with TB patient | ||
| Yes | 8 (9) | 5 (5) |
| No | 73 (82) | 88 (89) |
| Unknown | 8 (9) | 6 (6) |
a
Considering at least one of the tests positive.